17 studies found for:    M2e
Show Display Options
Rank Status Study
1 Completed
Has Results
Comparative Safety and Immunogenicity of 1.0 µg Intramuscular (i.m.) and 2.0 µg Subcutaneous (s.c.) Dosing With VAX102 (M2e-flagellin) Universal Influenza Vaccine in Healthy Adults
Condition: Influenza
Intervention: Biological: VAX102
2 Completed
Has Results
Safety Study of Recombinant M2e Influenza-A Vaccine in Healthy Adults
Condition: Influenza
Interventions: Biological: Influenza A Vaccine: ACAM FLU-A;   Biological: Saline placebo
3 Completed Open-label Study to Investigate the Humoral and Cellular Immune Response to Two Doses of VAX102 Influenza Vaccine in Healthy Adults
Condition: Influenza
Intervention: Biological: VAX102
4 Completed Phase I Safety and Immunogenicity Study of VAX102 [Flagellin.HuM2e] Influenza Vaccine in Healthy Adults
Condition: Influenza Infection
Interventions: Biological: VAX102 [Flagellin.HuM2e];   Biological: Placebo
5 Completed Genetic Expression and Prediction of Response to Neoadjuvant Docetaxel or Doxorubicin in Locally Advanced Breast Cancer
Condition: Breast Cancer
Interventions: Drug: docetaxel;   Drug: doxorubicin
6 Enrolling by invitation Study Of VGX-3400, H5N1 Avian Flu Virus Plasmid DNA With Electroporation Device In Healthy Adult Males
Condition: Healthy
Intervention: Biological: VGX-3400
7 Completed Dose-Finding Study of E7070 in Combination With Irinotecan
Condition: Cancer
Interventions: Drug: E7070 + irinotecan combination;   Drug: Irinotecan + E7070 combination
8 Completed Safety Study of Anti-Influenza Virus Monoclonal Antibody to Treat Influenza
Condition: Influenza, Human
Interventions: Biological: TCN-032;   Biological: Placebo
9 Completed Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Condition: Breast Cancer
Interventions: Drug: Raloxifene;   Drug: Tamoxifen
10 Completed Marimastat Following Chemotherapy in Treating Patients With Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: marimastat;   Drug: Placebo
11 Unknown  Carboplatin With or Without Gemcitabine in Treating Patients With Advanced Ovarian Epithelial Cancer That Has Not Responded to Previous Chemotherapy
Condition: Ovarian Cancer
Interventions: Drug: carboplatin;   Drug: gemcitabine hydrochloride
12 Completed Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer
Condition: Breast Cancer
Interventions: Drug: octreotide acetate;   Drug: tamoxifen citrate
13 Completed Flavopiridol in Treating Patients With Metastatic Malignant Melanoma
Condition: Melanoma (Skin)
Intervention: Drug: alvocidib
14 Completed Flavopiridol in Treating Patients With Recurrent, Locally Advanced, or Metastatic Soft Tissue Sarcoma
Condition: Sarcoma
Intervention: Drug: alvocidib
15 Completed Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: prednisone;   Drug: thalidomide
16 Completed ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: ISIS 5132
17 Completed Pethema Multiple Myeloma 2000
Condition: Multiple Myeloma
Interventions: Drug: Alternating chemotherapy;   Procedure: Autologous Transplantation;   Drug: Maintenance;   Procedure: Second transplantation;   Procedure: ALOGENIC MINI TRASPLANTATION

Indicates status has not been verified in more than two years